Found: 6
Select item for more details and to access through your institution.
Pharmaco-metabonomic phenotyping and personalized drug treatment.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Optimising the trade‐off between type I and II error rates in the Bayesian context.
- Published in:
- Pharmaceutical Statistics, 2021, v. 20, n. 4, p. 710, doi. 10.1002/pst.2102
- By:
- Publication type:
- Article
Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 3, p. 205, doi. 10.1002/pst.1675
- By:
- Publication type:
- Article
Statistical evaluation of biomarkers as surrogate endpoints: a literature review.
- Published in:
- Statistics in Medicine, 2006, v. 25, n. 2, p. 183, doi. 10.1002/sim.2319
- By:
- Publication type:
- Article
The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.
- Published in:
- Human Reproduction Update, 2011, v. 17, n. 6, p. 791, doi. 10.1093/humupd/dmr030
- By:
- Publication type:
- Article
Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In Pharmacovigilance.
- Published in:
- 2019
- By:
- Publication type:
- journal article